$0.3813
-0.01-3.37%
At close: -
$0.4178
0.049.57%
After Hours: 7:56 PM EDT
Comments
Loading...
Shuttle Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:SHPH | Benzinga
Shuttle Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Shuttle Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for Shuttle Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Shuttle Pharmaceuticals (SHPH) stock?
There is no price target for Shuttle Pharmaceuticals
What is the most recent analyst rating for Shuttle Pharmaceuticals (SHPH)?
There is no analyst for Shuttle Pharmaceuticals
When was the last upgrade for Shuttle Pharmaceuticals (SHPH)?
There is no last upgrade for Shuttle Pharmaceuticals
When was the last downgrade for Shuttle Pharmaceuticals (SHPH)?
There is no last downgrade for Shuttle Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Shuttle Pharmaceuticals (SHPH)?
There is no next analyst rating for Shuttle Pharmaceuticals.
Is the Analyst Rating Shuttle Pharmaceuticals (SHPH) correct?
There is no next analyst rating for Shuttle Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.